🇺🇸 FDA
Pipeline program

Recombinant Protein-Free Factor VIII (rAHF-PFM)

060402

Approved small_molecule completed

Quick answer

Recombinant Protein-Free Factor VIII (rAHF-PFM) for Hemophilia A is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Hemophilia A
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials